Coverart for item
The Resource Atrial Fibrillation and Percutaneous Coronary Intervention : A Case-based Guide to Oral Anticoagulation, Antiplatelet Therapy and Stenting

Atrial Fibrillation and Percutaneous Coronary Intervention : A Case-based Guide to Oral Anticoagulation, Antiplatelet Therapy and Stenting

Label
Atrial Fibrillation and Percutaneous Coronary Intervention : A Case-based Guide to Oral Anticoagulation, Antiplatelet Therapy and Stenting
Title
Atrial Fibrillation and Percutaneous Coronary Intervention
Title remainder
A Case-based Guide to Oral Anticoagulation, Antiplatelet Therapy and Stenting
Creator
Contributor
Subject
Language
eng
Cataloging source
MiAaPQ
Literary form
non fiction
Nature of contents
dictionaries
Atrial Fibrillation and Percutaneous Coronary Intervention : A Case-based Guide to Oral Anticoagulation, Antiplatelet Therapy and Stenting
Label
Atrial Fibrillation and Percutaneous Coronary Intervention : A Case-based Guide to Oral Anticoagulation, Antiplatelet Therapy and Stenting
Link
http://libproxy.rpi.edu/login?url=https://ebookcentral.proquest.com/lib/rpi/detail.action?docID=4755492
Publication
Copyright
Related Contributor
Related Location
Related Agents
Related Authorities
Related Subjects
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
  • Preface -- Contents -- 1: Atrial Fibrillation on Vitamin K Antagonist Undergoing Elective Percutaneous Coronary Intervention for Stable Effort Angina -- 1.1 Case Presentation -- 1.1.1 Baseline Characteristics -- 1.2 Periprocedural Issues -- 1.2.1 Periprocedural Management -- 1.3 Procedural Issues -- 1.3.1 Procedural Management -- 1.4 Post-procedural Issues -- 1.4.1 Post-procedural Management -- 1.5 Medium- to Long-Term Issues -- 1.5.1 Medium- to Long-Term Management -- 1.6 Long-Term Issues -- 1.6.1 Long-Term Management -- References -- 2: Atrial Fibrillation on Non-vitamin K Antagonist Oral Anticoagulant Undergoing Elective Percutaneous Coronary Intervention for Stable Effort Angina -- 2.1 Case Presentation -- 2.1.1 Baseline Characteristics -- 2.2 Periprocedural Issues -- 2.2.1 Periprocedural Management -- 2.3 Procedural Issues -- 2.3.1 Procedural Management -- 2.4 Post-procedural Issues -- 2.4.1 Post-procedural Management -- 2.5 Medium- to Long-Term Issues -- 2.5.1 Medium- to Long-Term Management -- 2.6 Long-Term Issues -- 2.6.1 Long-Term Management -- References -- 3: Atrial Fibrillation on Vitamin K Antagonist Undergoing Urgent Percutaneous Coronary Intervention for Non-ST-Elevation Acute Coronary Syndrome -- 3.1 Case Presentation -- 3.1.1 Baseline Characteristics -- 3.2 Periprocedural Issues -- 3.2.1 Periprocedural Management -- 3.3 Procedural Issues -- 3.3.1 Procedural Management -- 3.4 Post-procedural Issues -- 3.4.1 Post-procedural Management -- 3.5 Medium- to Long-Term Issues -- 3.5.1 Medium- to Long-Term Management -- References -- 4: Atrial Fibrillation on Vitamin K Antagonist Oral Anticoagulant Undergoing Urgent Percutaneous Coronary Intervention for Non-ST-Elevation Acute Coronary Syndrome -- 4.1 Case Presentation -- 4.1.1 Baseline Characteristics -- 4.2 Periprocedural Issues
  • 4.2.1 Periprocedural Management -- 4.3 Procedural Issues -- 4.3.1 Procedural Management -- 4.4 Post-procedural Issues (Table 4.14) -- 4.4.1 Post-procedural Management -- 4.5 Medium- to Long-Term Issues (Table 4.15) -- References -- 5: Atrial Fibrillation on Vitamin K Antagonist Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction -- 5.1 Case Presentation -- 5.1.1 Baseline Characteristics -- 5.2 Periprocedural Issues -- 5.2.1 Periprocedural Management -- 5.3 Procedural Issues -- 5.3.1 Procedural Management -- 5.4 Post-procedural Issues -- 5.4.1 Post-procedural Management -- 5.5 Medium- to Long-Term Issues -- 5.5.1 Medium- to Long-Term Management -- References -- 6: Atrial Fibrillation on Vitamin K Antagonist Oral Anticoagulant Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Acute Myocardial Infarction -- 6.1 Case Presentation -- 6.1.1 Baseline Characteristics -- 6.2 Periprocedural Issues -- 6.2.1 Periprocedural Management -- 6.3 Procedural Issues -- 6.3.1 Procedural Management -- 6.4 Post-procedural Issues -- 6.4.1 Post-procedural Management -- 6.5 Medium-Term Issues -- 6.5.1 Medium-Term Management -- 6.6 Long-Term Issues -- 6.6.1 Long-Term Management -- References -- 7: Atrial Fibrillation Early Complicating Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention -- 7.1 Case Presentation -- 7.1.1 Baseline Characteristics -- 7.2 Early Management Issues -- 7.2.1 Early Pharmacological Treatment -- 7.3 Risk Stratification -- 7.3.1 Early Management -- 7.4 The Issue of Choice and Management of Antithrombotic Therapy -- 7.4.1 Choice and Management of Antithrombotic Therapy -- 7.5 The Issue of the Choice of the Oral Anticoagulant to Be Added to DAPT -- 7.5.1 Choice and Management of Oral Anticoagulation
  • 7.6 The Issue of Post-discharge Management of Antithrombotic Therapy -- 7.6.1 Post-procedural Management -- References -- 8: New-Onset Atrial Fibrillation in a Stable Patient with Remote Percutaneous Coronary Intervention -- 8.1 Case Presentation -- 8.1.1 Baseline Characteristics -- 8.2 Management Issues -- 8.2.1 In-hospital Management -- 8.3 Choice and Management of Oral Anticoagulation -- 8.3.1 Discharge Therapy and Recommendations -- References -- 9: Urgent Surgery Early After Percutaneous Coronary Intervention in a Patient with Atrial Fibrillation on Triple Therapy with a Vitamin K Antagonist, Aspirin, and Clopidogrel -- 9.1 Case Presentation -- 9.1.1 Baseline Characteristics -- 9.2 Peri-procedural Issues -- 9.2.1 Peri-procedural Management -- 9.3 Post-procedural Issues -- 9.3.1 Post-procedural Management -- References -- 10: Urgent Surgery Early After Percutaneous Coronary Intervention in a Patient with Atrial Fibrillation on Triple Therapy of Non-{u00AD}vitamin K Antagonist Oral Anticoagulant, Aspirin, and Clopidogrel -- 10.1 Case Presentation -- 10.1.1 Baseline Characteristics -- 10.2 Perioperative Issues -- 10.2.1 Perioperative Management -- 10.3 Postoperative Issues -- 10.3.1 Postoperative Management -- References -- 11: Major Bleeding Early After Percutaneous Coronary Intervention in a Patient with Atrial Fibrillation on Triple Therapy with Vitamin K antagonist, Aspirin, and Clopidogrel -- 11.1 Case Presentation -- 11.1.1 Baseline Characteristics -- 11.2 Early Evaluation Issues -- 11.2.1 Initial Evaluation -- 11.3 Early Management Issues -- 11.3.1 Early Management -- 11.4 Post-acute Issues -- 11.4.1 Long-Term Management -- References
  • 12: Major Bleeding Early After Percutaneous Coronary Intervention in a Patient with Atrial Fibrillation on Triple Therapy with a Non-vitamin K-Antagonist Oral Anticoagulant, Aspirin, and Clopidogrel -- 12.1 Case Presentation -- 12.1.1 Baseline Characteristics -- 12.2 Early Management Issues -- 12.2.1 Initial Management -- 12.3 Further Management Issues -- 12.3.1 Further Management -- 12.4 Post-acute Issues -- 12.4.1 Long-Term Management -- References
http://library.link/vocab/cover_art
https://contentcafe2.btol.com/ContentCafe/Jacket.aspx?Return=1&Type=S&Value=9783319424002&userID=ebsco-test&password=ebsco-test
Dimensions
unknown
http://library.link/vocab/discovery_link
{'f': 'http://opac.lib.rpi.edu/record=b4386780'}
Extent
1 online resource (217 pages)
Form of item
online
Isbn
9783319424002
Media category
computer
Media MARC source
rdamedia
Media type code
c
Sound
unknown sound
Specific material designation
remote

Library Locations

    • Folsom LibraryBorrow it
      110 8th St, Troy, NY, 12180, US
      42.729766 -73.682577
Processing Feedback ...